Self-Motivated Supramolecular Combination Chemotherapy for Overcoming Drug Resistance Based on Acid-Activated Competition of Host–Guest Interactions

Hua Wang,Han Wu,Yu Yi,Ke-Fei Xue,Jiang-Fei Xu,Hao Wang,Yuliang Zhao,Xi Zhang
DOI: https://doi.org/10.31635/ccschem.021.202100964
2021-01-01
CCS Chemistry
Abstract:In this work, we propose a nanoparticle-based strategy of self-motivated supramolecular combination chemotherapy that carries drugs stably and releases them actively in the acidic tumor microenvironment to overcome the drug resistance of cancer cells. This self-motivated nanoparticle consists of a cucurbit [7]uril-containing polymer (PCB)-based core, in which the oxaliplatin and a mitochondria-targeting cytotoxic peptide with an N-terminal phenylalanine are stably loaded through host-guest interactions, and a polymeric protection shell containing acid-activated competitors for releasing drugs. In the acidic tumor environment, the protected aminomethyl phenylalanine moieties on the polymer shell were recovered with a remarkable increase in the binding constant toward cucurbit[7]uril, which competitively replaced and released the combination drugs in PCB. With the synergistic effect of released mitochondria-targeting cytotoxic peptides that effectively inhibited the energy-dependent drug efflux, this self-motivated nanoparticle augmented the anticancer activity of oxaliplatin against drug-resistant cells. This strategy of self-motivated supramolecular combination chemotherapy provides a new method for efficient combination of chemical drugs and bioactive peptides with on-demand drug release, and opens a great prospect for supramolecular chemotherapy toward overcoming the drug resistance of cancers. [GRAPHICS] .
What problem does this paper attempt to address?